Titlebook: Cardiac Arrhythmias, Pacing and Sudden Death; Peter Kowey,Jonathan P. Piccini,James A. Reiffel Book 2017 Springer International Publishing

輕浮女

Implantable and Wearable Defibrillator Therapy,primary and secondary prevention of sudden cardiac death. When used in conjunction with cardiac resynchronization therapy for patients with impaired left ventricular function, left bundle-branch block, and heart failure, ICDs have resulted in decreased heart failure hospitalizations and prolonged su

違抗

事情

鋼盔

緯度

Clinical Management of Atrial Fibrillation,etermination of AF type (paroxysmal or persistent), burden, symptoms, and risk for thromboembolism and stroke. Treatment strategies can then be selected focusing on rate vs. rhythm control and stroke risk reduction. Rate control is typically achieved with medical therapy, but AV junctional ablation

英寸

高貴領(lǐng)導(dǎo)

HOWL

Bradyarrhythmias/Heart Blocks,he cardiac electrophysiological system are reviewed to provide a framework for an understanding of the patterns of sinus node, AV node, and His-Purkinje system dysfunction that result in clinical bradyarrhythmias. The important pathologic processes leading to these clinical bradyarrhythmias are disc

deciduous

Syncope and Risk of Sudden Death, are presumed to have had syncope. However, before a clinician can attempt to assess mortality risk relative to an episode of syncope, it is first essential to determine that collapse was in fact due to syncope (i.e., transient self-limited loss of consciousness due to cerebral hypoperfusion) and no

jovial

Atrial Fibrillation Ablation,arrhythmic medications and in selected patients with symptomatic, paroxysmal AF . to a trial of medical therapy, provided that it can be performed at an experienced center. In this chapter, we summarize the state of the art of catheter ablation and how it may utilized to its maximum advantage in patients with this common arrhythmia.